Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Abivax (AAVXF) Net Margin (2024 - 2025)

Historic Net Margin for Abivax (AAVXF) over the last 2 years, with Q3 2025 value amounting to 195.43%.

  • Abivax's Net Margin rose 3682300.0% to 195.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 361.09%, marking a year-over-year increase of 5340700.0%. This contributed to the annual value of 1415.71% for FY2024, which is 17814300.0% up from last year.
  • Abivax's Net Margin amounted to 195.43% in Q3 2025, which was up 3682300.0% from 922.7% recorded in Q2 2025.
  • Abivax's Net Margin's 5-year high stood at 130.71% during Q4 2024, with a 5-year trough of 922.7% in Q2 2025.